Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21020005 | 0.90 | SIGMAR1 (0.33) | NPC1SIGMAR1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL21020007 | 0.86 | CYP2D6 (0.38) | NPC1SIGMAR1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL20172884 | 0.82 | TP53 (0.36) | NPC1CYP1A2CYP2D6CYP2C19MEN1 | |
| SCHEMBL21020006 | 0.82 | SIGMAR1 (0.35) | SIGMAR1CYP1A2MEN1KMT2A | |
| SCHEMBL20172887 | 0.82 | ALDH1A1 (0.35) | NPC1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL20172865 | 0.81 | L3MBTL1 (0.40) | NPC1CYP1A2CYP2D6CYP2C19MEN1 | |
| SCHEMBL21020457 | 0.81 | SIGMAR1 (0.33) | SIGMAR1 | |
| SCHEMBL20172937 | 0.79 | NPC1 (0.36) | NPC1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL21021038 | 0.79 | SIGMAR1 (0.33) | SIGMAR1 | |
| SCHEMBL20172905 | 0.79 | LMNA (0.33) | NPC1SIGMAR1CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | NPC1 1478/4885SIGMAR1 2480/4885CYP1A2 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.